Sweden has extended its pause of the Moderna COVID-19 vaccine for people aged 30 and younger due to heart-related side-effects, the public health agency announced on Oct. 21. The European Medicines Agency approved the use of Moderna’s Spikevax for children aged over 12 in July, marking the first time the shot had been authorized for use in people under 18. But on Oct. 6, the Public Health Agency of Sweden said it was pausing the use of Spikevax among people born in 1991 or later after data showed an increased risk of inflammation of the heart muscle (myocarditis) or the sac surrounding the heart (pericarditis). The initial pause had a deadline of Dec. 1. But the agency announced Thursday that it was extending that pause beyond the original deadline for people aged 30 and younger and anyone who has received a first dose of Spikevax is recommended to receive Pfizer’s Comirnaty as a second dose instead. The European Medicines Agency approved …
RSS Feed | The Epoch Times